Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-curcumin and HIIT exercise for PCOS complications in women undergoing ICSI
IRCT20210207050279N1Phase 3Completed
- Sponsor
- ACECR
- Start
- Dec 2023
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of nanocurcumin in polycystic ovary syndrome (PCOS), sponsored by ACECR. Started Dec 2023; status: completed.
02
Drugs
nanocurcumin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20210207050279N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210207050279N1.